Compare Globus Medical Inc. Class A Common Stock (GMED) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Alliant Energy Corporation — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Alliant Energy Corporation trades at $67.7 (market cap $17.51B). The key difference: Alliant Energy Corporation is the larger of the two by market cap, and Alliant Energy Corporation pays a 3.17% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Alliant Energy Corporation for 65 Days on average.
| GMED | LNT | |
|---|---|---|
Market Cap | $10.25B | $17.51B |
Volume | 1,059,528 | 2,397,331 |
Sector | Health | Utilities |
52-Week High | $96.82 | $78.03 |
52-Week Low | $58.33 | $63.21 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $9.76B | $29.60B |
Dividend Yield | — | 3.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
LNT trades at $66.96, up 0.75% today, with a bullish technical signal despite mixed momentum indicators. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $0.65 versus $0.579, and revenue growth to $4.36B in 2025. Recent news highlights a $1.4B partnership with CareTrust REIT and institutional buying interest.
Outlook remains positive with analyst consensus price target of $74.00 (10.5% upside) and no sell ratings. Key risks include rising debt levels (debt-to-asset ratio up to 48.48% in 2025) and execution of $13.4B capital expenditure plan. The stock offers defensive utility exposure with 23-year dividend growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
